Adrian Tersteegen

This inventor holds 53 USPTO granted patents and 35 published patent applications, plus 7 CIPO patents and 33 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Bayer Pharma Aktiengesellschaft, Boehringer Ingelheim International Gmbh, Bayer Intellectual Property Gmbh. Active years: 2005-2025.

USPTO Granted Patents = 53 (Patent Applications = 35)

% Patents Active = 56.6

CIPO Patents = 7 (Patent Applications = 16)

EPO Patents = 33 (Patent Applications = 52)

Average Co-Inventor Count = 9.4

ph-index = 11

Forward Citations = 377(Granted Patents)

Forward Citations (Not Self Cited) = 308(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Velbert, DE (2005 - 2014)
Wuppertal, DE (2009 - 2024)

Company Filing History:

30 out of 380

Bayer Pharma Aktiengesellschaft

patents

11 out of 1,560

Boehringer Ingelheim International Gmbh

patents

10 out of 721

Bayer Intellectual Property Gmbh

patents

4. 7 out of 12,223

Bayer Aktiengesellschaft

patents

5. 4 out of 480

The Broad Institute, Inc.

patents

6. 3 out of 1,264

Dana-Farber-Cancer Institute Inc.

patents

7. 2 out of 77

Bayer Healthcare Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

MASP Inhibitors

Oxopyridine Derivatives

Hyperproliferative Diseases

Bicyclic Uracils

Factor XIa Inhibitors

Cardiovascular Disorders

Triazine Compounds

Pyrazolo[3,4-b]pyridines

Imidazo Compounds

Oxazolidinones

Pyrimidine Derivatives

GSK3 Inhibitors

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503491 - MASP INHIBITORY COMPOUNDS AND USES THEREOF (2025-12-23),

2. 12427153 - 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases (2025-09-30),

3. 12258323 - Dihydrooxadiazinones (2025-03-25),

4. 11912692 - Substituted S-alaninate derivatives (2024-02-27),

5. 11884660 - Substituted oxopyridine derivative (2024-01-30),

6. 11773070 - Dihydrooxadiazinones (2023-10-03),

7. 11667675 - MASP inhibitory compounds and uses thereof (2023-06-06),

8. 11427553 - Dihydrooxadiazinones (2022-08-30),

9. 11180471 - Substituted oxopyridine derivatives (2021-11-23),

10. 10421742 - Substituted oxopyridine derivatives (2019-09-24),

11. 10414731 - Substituted oxopyridine derivatives (2019-09-17),

12. 10300062 - Bicyclically substituted uracils and the use thereof (2019-05-28),

13. 10183932 - Substituted oxopyridine derivatives and use thereof cardiovascular disorders (2019-01-22),

14. 10167280 - Substituted oxopyridine derivatives (2019-01-01),

15. 10138236 - Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives (2018-11-27),

Title: The Innovative Mind of Adrian Tersteegen

Introduction: Adrian Tersteegen, a talented inventor hailing from Wuppertal, Germany, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Adrian Tersteegen holds several patents in the areas of renewable energy technologies, smart devices, and sustainable materials. His most recent patent involves a revolutionary method for harnessing solar energy efficiently in urban environments.

Career Highlights: With a career spanning over two decades, Adrian Tersteegen has worked tirelessly to bring his innovative ideas to life. He has successfully developed and patented numerous inventions that have had a significant impact on various industries.

Collaborations: Throughout his career, Adrian Tersteegen has collaborated with leading research institutions, universities, and tech companies to further advance his inventions. His collaborative efforts have resulted in the successful commercialization of several groundbreaking technologies.

Conclusion: Adrian Tersteegen's passion for innovation and his relentless pursuit of technological advancement have solidified his reputation as a visionary inventor in the global innovation landscape. His contributions continue to inspire future generations of inventors and innovators.